After careful selection and consideration, George Clinical’s (GC) Evon Hui of the Hong Kong office has accepted the position of Associate Director, Business Operations, East Asia (EA) and will be reporting directly to Marisa Petersen, Chief Executive Officer of GC. Evon joined GC in November 2012 as the Regional Clinical Operations Manager (COM) for the […]
Read More
From the 30th March – 1 April 2016, George Clinical will be exhibiting at the largest Bio exhibition in Asia – Bio Korea 2016, held in Seoul. BioKorea, established in 2006, has grown to be one of Asia’s premier events for global biotech industry. This year marks the 11th anniversary for this conference. BioKorea consists […]
Read MoreThe Malaysian government has committed funding to improve the healthcare systems in order to further support clinical research. Clinical Research Malaysia (CRM) is a non-profit organisation – wholly owned by the government of Malaysia, which intends to develop infrastructure for the Clinical Research Centre networks, and be able to support global industry sponsored research (ISR) […]
Read More
George Clinical (GC) conducted a brief survey on sponsors who are currently not a customer of GC. 30 companies were surveyed by GC’s Business Development Managers across six countries which included the United States, China, Australia, Korea, United Kingdom and Israel. The primary objective of the survey was to determine the services and countries that were important […]
Read More
The cost of employee turnover in a Clinical Research Organisation (CRO) is high, as it weakens the relationship with the project sponsor. Research shows that in 2012, the CRO industry in the United States experienced a 12.5% voluntary turnover, compared to an average national voluntary turnover rate of 1.5%. During the 2015 financial year, George Clinical […]
Read MoreIn a surprise move, the State Council in China has recently released a directive announcing its view on reforming the drug and medical device review and approval process in China. The State Council oversees the Chinese Food and Drug Administration (CFDA), and it is noteworthy that these changes were announced at a high level, reflecting […]
Read MoreGeorge Clinical in China recently celebrated its second anniversary as an independent entity in China. Although George Clinical has been conducting Phase 11 to Phase IV studies in China for over 8 years, previously it was incorporated into The George Institute in China – but now operates as a separate legal entity. The last two […]
Read MoreGeorge Clinical (GC) is at the heart of developing Asia Clinical Research Professionals. This summer, our Clinical and Regulatory Manager, East Asia volunteered as a trainer for Asia Training Consortium (ATC) in its Foundational Clinical Project Management training program in Hong Kong. ATC is a non-profit organisation aimed at providing a unified platform for industry […]
Read MoreThe George Institute was recently profiled in The Lancet; revered as one of the most prestigious, peer reviewed medical journals in the world. The Lancet Vol. 385 April 18, 2015 The feature article in The Lancet spoke of the Institute’s 16 year history from inception to the present time, where the George Institute is known […]
Read More
